top of page

Buy Cerebrolysin injection online. PayPal

 

Pharmacological group: Neurometabolic stimulants.

 

Dosage form: ampoules (1 ml, 2 ml, 5 ml, 10 ml, 20 ml).

 

Brand: EVER Pharma Austria.

 

Manufacturer: EVER Neuro Pharma GmbH, Austria.

 

Release form: One package of Cerebrolysin consists of 5 or 10 ampoules.

 

Cerebrolysin is a peptide obtained biotechnologically from the brain of a pig. It stimulates neurotrophic regulation of the central nervous system. Cerebrolysin is used all over the world to treat ischemic and hemorrhagic stroke, traumatic brain injury, various forms of dementia (vascular dementia, Alzheimer's disease), cognitive disorders and to prevent cognitive decline after brain injury. Patients with acute or degenerative neurological diseases benefit from the neuroprotective and neuroregenerative properties of Cerebrolysin.

 

We accept payments via PayPal.

This means that PayPal guarantees 100% protection of your funds and guarantees reship or refund in case of possible delivery problems.

Also we take care of all fees for transfer and currency exchange.

 

All payments are 100% secure.

 

To view PayPal buyers protection, please click here:

https://www.paypal.com/us/webapps/mpp/paypal-safety-and-security

 

If you have any questions regarding dosage, delivery, payment - you can contact directly by email: mikhail@pharmamama.com or fill out the form on our website.

Buy Cerebrolysin (aka FPF-1070)

PriceFrom $25.00
  • It has been studied since the early 1970s and is a staple product of the Austrian pharmaceutical company EVER Neuro Pharma, which additionally includes Parkinson's treatments and nutritional supplements. There is no international name for the drug.

    In 2011, a double-blind, placebo-controlled study was conducted in patients with mild to moderate vascular dementia. The results of which showed that the appointment of Cerebrolysin at a dose of 20 ml / day for the treatment of patients with mild or moderate dementia:

    • is safe and clinically effective;
    • the beneficial effect lasts at least 24 weeks;
    • since the improvement continued up to 8 weeks after active treatment, the effect of the drug Cerebrolysin, obviously, goes beyond the limits of symptomatic treatment;
    • is a cost-effective and cost-effective strategy for the treatment of patients with vascular dementia;
    • can be recommended for inclusion in the regional formulary of treatment of patients with vascular dementia.

    The pharmacoeconomic study was funded by the pharmaceutical company EVER Neuro Pharma GmbH, Austria, but this did not affect the study results. (Journal "Qualitative clinical practice" No. 1, 2011, article "Clinical and economic analysis of treatment of vascular dementia with Cerebrolysin" Gekht AB, Pavlov N.A., Gudkova A.A., Belousov D.Yu., Afanasyeva E.V., Belousov Yu.B., Repyev A.P.)

    For more than 40 years, Cerebrolysin has been widely used in Russia and the CIS countries. For many years (since 1992) it has been on the government's list of essential drugs. (USA) is not registered, but has the status of a new drug approved by the FDA for private clinical use.

bottom of page